Home›Stock Screener›Gennex Laboratories›Financial Statements

Gennex Laboratories Complete Financial Statements

10 Years of Data
2026 - 2017

In FY2026, Gennex Laboratories (GENNEX) reported revenue ₹62 Cr, net profit ₹5 Cr and EPS ₹0.16, with a net profit margin of 8.1% and ROE of 2.2%. Full financial statements from FY2017 to FY2026 (10 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Analyse Gennex Laboratories ownership pattern to track promoter, FII and institutional holdings.

Complete Financial Data Export

Profitability Ratios

Net Profit Margin 8.06% 2026 data
EBITDA Margin 11.29% 2026 data
Operating Margin 9.00% 2026 data
Return on Assets 1.43% 2026 data
Return on Equity 2.24% 2026 data

Balance Sheet Ratios

Current Ratio 6.16 2026 data
Equity Ratio 63.90% 2026 data
Asset Turnover 0.18 2026 data

GENNEX Revenue, Net Profit & EBITDA — Year-on-Year Growth

GENNEX YoY (Mar 2025 vs Mar 2026) — revenue +40.9%, net profit +66.7%, EBITDA +16.7%, expenses +41.0%. For live price, earnings ratios and company overview, see Gennex Laboratories screener.

Revenue Growth
+40.9%
Year-over-Year
Net Profit Growth
+66.7%
Year-over-Year
EBITDA Growth
+16.7%
Year-over-Year
Expense Growth
+41.0%
Year-over-Year
Assets Growth
+36.3%
Year-over-Year
Equity Growth
+14.4%
Year-over-Year
Operating Cash Flow Growth
+76.6%
Year-over-Year
Investing Cash Flow Growth
-94.7%
Year-over-Year
Financing Cash Flow Growth
-93.2%
Year-over-Year

GENNEX Income Statement — Revenue, EBITDA & Net Profit

Gennex Laboratories revenue ₹62 Cr, EBITDA ₹7 Cr, net profit ₹5 Cr, EPS ₹0.16 (2026) — net profit margin 8.1%. Examine GENNEX Q4 results for recent quarterly revenue, profit and EPS trends.

Periods ₹ Crores
Particulars Mar 2026 Sept 2025 Mar 2025 Jun 2025 Dec 2025 Sept 2024 Mar 2024 Jun 2024 Dec 2024 Sept 2023 Mar 2023 Jun 2023 Dec 2023 Sept 2022 Mar 2022 Jun 2022 Dec 2022 Sept 2021 Mar 2021 Jun 2021 Dec 2021 Sept 2020 Mar 2020 Jun 2020 Dec 2020 Sept 2019 Mar 2019 Jun 2019 Dec 2019 Sept 2018 Mar 2018 Jun 2018 Dec 2018 Sept 2017 Jun 2017 Dec 2017
Revenue 62 37 44 37 40 32 34 31 38 18 19 17 19 19 20 14 14 14 16 10 17 15 12 13 15 14 21 16 15 11 14 10 15 11 8 12
Expenses 55 32 39 29 35 26 29 24 33 12 17 11 17 18 19 13 13 12 14 9 15 14 11 12 14 13 19 15 14 10 14 9 14 10 7 11
EBITDA 7 6 6 7 6 6 4 7 5 5 1 5 3 1 1 1 1 2 3 2 1 2 1 1 2 1 2 2 1 1 1 1 1 1 1 1
Operating Profit Margin % 9.00% 15.00% 5.00% 15.00% 14.00% 18.00% 13.00% 15.00% 13.00% 29.00% 7.00% 31.00% 13.00% 7.00% 4.00% 6.00% 8.00% 13.00% 16.00% 16.00% 7.00% 10.00% 5.00% 6.00% 11.00% 7.00% 7.00% 8.00% 4.00% 7.00% -1.00% 8.00% 8.00% 8.00% 9.00% 7.00%
Depreciation 1 1 1 1 1 1 0 0 1 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Interest 1 1 1 1 1 0 1 1 1 1 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 5 6 4 6 7 6 5 6 6 4 3 4 4 1 1 1 2 2 2 1 1 1 0 1 2 1 1 1 0 1 0 1 1 0 0 1
Tax 0 1 1 1 1 1 1 1 1 1 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0
Net Profit 5 6 3 5 6 5 5 5 5 3 2 3 3 1 1 1 1 1 2 1 1 1 0 0 1 1 0 1 0 1 0 1 1 0 0 0
Earnings Per Share (₹) 0.16 0.21 0.14 0.22 0.22 0.21 0.16 0.19 0.22 0.16 0.19 0.16 0.16 0.08 0.10 0.06 0.07 0.09 0.15 0.08 0.06 0.07 0.02 0.03 0.10 0.04 0.02 0.06 0.02 0.04 -0.02 0.03 0.07 0.03 0.03 0.02

GENNEX Balance Sheet — Assets, Liabilities & Shareholders' Equity

GENNEX total assets ₹349 Cr, total equity ₹223 Cr, total liabilities ₹ Cr (2026) — ROE 2.2%.

Years Annual Data ₹ Crores
Particulars 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017
ASSETS
Total Assets 349 256 230 132 68 59 57 52 51 49
Current Assets 265 181 162 49 47 38 35 29 28 26
Fixed Assets 74 60 56 74 14 14 15 16 16 16
Capital Work in Progress 13 5 2 0 0 0 0 0 0 0
Investments 54 0 0 0 7 7 7 7 7 7
Other Assets 0 191 172 59 48 38 35 29 28 27
LIABILITIES
Total Liabilities
Current Liabilities 43 17 13 16 0 0 0 1 1 1
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 223 195 177 87 44 40 36 34 32 31
Share Capital 24 23 23 18 13 13 13 13 13 13
Reserves & Surplus 198 158 142 62 31 27 23 21 19 18

GENNEX Cash Flow Statement — Operating, Investing & Financing

Gennex Laboratories operating cash flow ₹-11 Cr, investing ₹1 Cr, financing ₹5 Cr, net cash flow ₹-5 Cr (2025).

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017
Operating Activities -11 -47 24 12 -1 -2 2 3 0
Investing Activities 1 19 -38 -3 0 0 -1 -1 -1
Financing Activities 5 74 21 -2 2 0 1 -2 1
Net Cash Flow -5 46 6 8 0 -2 2 0 0